Episode Details

In this lesson, we delve into the evolving landscape of regulatory guidance for artificial intelligence and machine learning in medical software. As AI/ML technologies hold immense promise for healthcare, regulators worldwide are grappling with the challenge of fostering innovation while ensuring patient safety, particularly concerning self-updating algorithms and the critical role of data management. We explore various international frameworks and the complexities of ensuring robust, explainable AI in medical applications.

🎯 Learning Objectives
• Understand the regulatory challenges associated with AI/ML in medical software, balancing innovation with patient safety.
• Identify key aspects of international regulatory guidance from Germany, China, and the FDA, including AI life cycle, data management, and validation.
• Differentiate between interpretable AI and explainable AI in the context of regulatory requirements like the GDPR’s “right to an explanation.”
• Recognize the paradigm shift from code to data as the most critical aspect in developing and regulating machine learning models.
• Explain the importance of robust testing and validation strategies for AI/ML algorithms, including prospective vs. retrospective trials and independent evaluation.

Learn more about your ad choices. Visit megaphone.fm/adchoices